Jin Xing Qi
Chairman presso HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD
Patrimonio netto: 1 642 M $ in data 31/03/2024
Profilo
Jin Xing Qi ha fondato Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Attualmente è presidente di Hangzhou Binjiang Real Estate Group Co., Ltd. e presidente di Hangzhou Pute Equity Investment Co. Ltd. Il signor Qi è anche nel consiglio di Hangzhou Binjiang Investment Holding Co., Ltd. e Hangzhou Xincheng Time Square Real Estate Co., Ltd. e vicepresidente della Zhejiang Management Research. In passato il signor Qi ha ricoperto la posizione di direttore presso Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Jin Xing Qi ha ricevuto un MBA dalla Zhejiang University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/09/2023 | 1 505 912 522 ( 55.93% ) | 1 386 M $ | 31/03/2024 | |
| 30/09/2023 | 278 698 950 ( 64.95% ) | 256 M $ | 31/03/2024 |
Posizioni attive di Jin Xing Qi
| Società | Posizione | Inizio |
|---|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Chairman | 01/01/2003 |
| Zhejiang Management Research | Corporate Officer/Principal | 24/02/2010 |
| Hangzhou Pute Equity Investment Co. Ltd. | Chairman | 07/04/2011 |
Hangzhou Binjiang Investment Holding Co., Ltd.
 Hangzhou Binjiang Investment Holding Co., Ltd. MiscellaneousMiscellaneous Hangzhou Binjiang Investment Holding Co., Ltd. is an investment holding private company based in Hangzhou, China. | Director/Board Member | - |
Hangzhou Xincheng Time Square Real Estate Co., Ltd.
 Hangzhou Xincheng Time Square Real Estate Co., Ltd. Real Estate DevelopmentFinance Part of Hangzhou Binjiang Real Estate Group Co., Ltd., Hangzhou Xincheng Time Square Real Estate Co., Ltd. develops and manages real estate property. The private company is based in Hangzhou, China. | Director/Board Member | - |
Precedenti posizioni note di Jin Xing Qi
| Società | Posizione | Fine |
|---|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Founder | - |
Formazione di Jin Xing Qi
| Zhejiang University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Finance |
| Aziende private | 5 |
|---|---|
Hangzhou Binjiang Investment Holding Co., Ltd.
Hangzhou Binjiang Investment Holding Co., Ltd. MiscellaneousMiscellaneous Hangzhou Binjiang Investment Holding Co., Ltd. is an investment holding private company based in Hangzhou, China. | Miscellaneous |
| Zhejiang Management Research | |
Hangzhou Xincheng Time Square Real Estate Co., Ltd.
Hangzhou Xincheng Time Square Real Estate Co., Ltd. Real Estate DevelopmentFinance Part of Hangzhou Binjiang Real Estate Group Co., Ltd., Hangzhou Xincheng Time Square Real Estate Co., Ltd. develops and manages real estate property. The private company is based in Hangzhou, China. | Finance |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
| Hangzhou Pute Equity Investment Co. Ltd. | Finance |
- Borsa valori
- Insiders
- Jin Xing Qi
